- Investor's Business Daily•2 hours ago
Biogen could add another $1 billion in 2017 sales if its myotonic dystrophy drug garners strong trials data by year's end, says an analyst.
- 24/7 Wall St.•4 hours ago
Eli Lilly plans to release its most recent earnings report before the markets open on Tuesday, and analysts expect top and bottom line growth.
Eli Lilly and Company (LLY)
NYSE - NYSE Real Time Price. Currency in USD
|Bid||77.69 x 600|
|Ask||77.70 x 800|
|Day's Range||77.44 - 78.69|
|52wk Range||67.88 - 88.16|
|1y Target Est||N/A|
Trade prices are not sourced from all markets
|P/E Ratio (ttm)||33.40|
|Avg Vol (3m)||3,440,703|
|Dividend & Yield||2.04 (2.61%)|